1,566 Shares in Teleflex Incorporated (TFX) Purchased by Clinton Group Inc.
Clinton Group Inc. bought a new position in shares of Teleflex Incorporated (NYSE:TFX) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,566 shares of the medical technology company’s stock, valued at approximately $325,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Employees Retirement System of Texas increased its position in shares of Teleflex by 62.5% during the second quarter. Employees Retirement System of Texas now owns 13,000 shares of the medical technology company’s stock worth $2,701,000 after purchasing an additional 5,000 shares in the last quarter. HighTower Advisors LLC acquired a new stake in shares of Teleflex during the second quarter worth about $382,000. Balyasny Asset Management LLC increased its position in shares of Teleflex by 245.8% during the second quarter. Balyasny Asset Management LLC now owns 16,019 shares of the medical technology company’s stock worth $3,328,000 after purchasing an additional 11,387 shares in the last quarter. Stifel Financial Corp increased its position in shares of Teleflex by 0.6% during the second quarter. Stifel Financial Corp now owns 5,399 shares of the medical technology company’s stock worth $1,121,000 after purchasing an additional 31 shares in the last quarter. Finally, Voya Investment Management LLC increased its position in shares of Teleflex by 39.2% during the second quarter. Voya Investment Management LLC now owns 19,566 shares of the medical technology company’s stock worth $4,065,000 after purchasing an additional 5,510 shares in the last quarter. Institutional investors and hedge funds own 89.75% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/10/09/1566-shares-in-teleflex-incorporated-tfx-purchased-by-clinton-group-inc.html.
TFX has been the topic of a number of research analyst reports. Morgan Stanley upgraded Teleflex from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $220.00 to $274.00 in a research report on Wednesday, September 6th. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $261.00 target price on the stock in a research report on Tuesday, September 12th. Jefferies Group LLC lifted their target price on Teleflex from $253.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, September 8th. Barclays PLC reiterated a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. Finally, Needham & Company LLC lifted their target price on Teleflex from $228.00 to $237.00 and gave the stock a “buy” rating in a research report on Tuesday, September 5th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $260.75.
Teleflex Incorporated (NYSE TFX) opened at 246.05 on Monday. The stock has a market cap of $11.08 billion, a price-to-earnings ratio of 47.05 and a beta of 1.07. The company’s 50 day moving average price is $228.55 and its 200-day moving average price is $209.38. Teleflex Incorporated has a 12-month low of $136.53 and a 12-month high of $248.68.
Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.13. The firm had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. Teleflex’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.89 earnings per share. On average, analysts forecast that Teleflex Incorporated will post $8.28 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Tuesday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 11th. This represents a $1.36 annualized dividend and a yield of 0.55%. Teleflex’s dividend payout ratio (DPR) is 26.00%.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $211.75, for a total transaction of $42,350.00. Following the sale, the director now owns 8,080 shares in the company, valued at $1,710,940. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last quarter, insiders have sold 600 shares of company stock worth $132,408. 2.39% of the stock is owned by company insiders.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.